Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safetyWei Wei, Rong Guo, Pei‐En Jian et al.|癌症：英文版|2018Cited by 189
Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort studyLianghe Lu, Yong‐Fa Zhang, Chong Zhong et al.|Liver International|2020Cited by 62
Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative studyYong‐Fa Zhang, Ming Shi, Xiang‐Ming Lao et al.|European Radiology|2015Cited by 53
MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinomaHanyue Ouyang, Ming Shi, Jing Xu et al.|Hepatology|2015Cited by 49
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablationLianghe Lu, Rong Guo, Jie Mei et al.|Cancer Medicine|2020Cited by 45